First Circuit asks Sanofi to prove patent claims were in good faith
Direct purchasers stated a claim for monopolisation against Sanofi-Aventis, the US Court of Appeals for the First Circuit has held, and the drugmaker must prove its defence was in good faith.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10